The use of interferon-alpha in Behçet's disease--review of the literature and possible mechanisms of action.
Kötter
Ina
I
University Hospital, Department of Internal Medicine II (Hematology, Oncology, Immunology, Rheumatology), Tübingen, Germany.
Günaydin
Ilhan
I
Treusch
Michaela
M
Zierhut
Manfred
M
Kanz
Lothar
L
Stübiger
Nicole
N
D001528:Behcet Syndrome / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D011994:Recombinant Proteins
D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins